nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Mean arterial pressure—Fingolimod—multiple sclerosis	0.252	0.261	CcSEcCtD
Cisatracurium Besylate—Hypoxemia—Methotrexate—multiple sclerosis	0.0195	0.0201	CcSEcCtD
Cisatracurium Besylate—Doxacurium chloride—BCHE—multiple sclerosis	0.0173	0.515	CrCbGaD
Cisatracurium Besylate—Mivacurium—BCHE—multiple sclerosis	0.0163	0.485	CrCbGaD
Cisatracurium Besylate—Cardiac arrest—Fingolimod—multiple sclerosis	0.0145	0.015	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisolone—multiple sclerosis	0.0135	0.014	CcSEcCtD
Cisatracurium Besylate—Trauma—Triamcinolone—multiple sclerosis	0.0124	0.0128	CcSEcCtD
Cisatracurium Besylate—Trauma—Methylprednisolone—multiple sclerosis	0.0124	0.0128	CcSEcCtD
Cisatracurium Besylate—Wheezing—Cladribine—multiple sclerosis	0.0116	0.012	CcSEcCtD
Cisatracurium Besylate—Trauma—Betamethasone—multiple sclerosis	0.0113	0.0117	CcSEcCtD
Cisatracurium Besylate—Trauma—Dexamethasone—multiple sclerosis	0.0113	0.0117	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Fingolimod—multiple sclerosis	0.0108	0.0111	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Fingolimod—multiple sclerosis	0.0104	0.0107	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisone—multiple sclerosis	0.00981	0.0102	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Fingolimod—multiple sclerosis	0.00958	0.00992	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00952	0.00985	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisolone—multiple sclerosis	0.00917	0.00949	CcSEcCtD
Cisatracurium Besylate—Myopathy—Triamcinolone—multiple sclerosis	0.00843	0.00872	CcSEcCtD
Cisatracurium Besylate—Myopathy—Methylprednisolone—multiple sclerosis	0.00841	0.0087	CcSEcCtD
Cisatracurium Besylate—Hypertension—Fingolimod—multiple sclerosis	0.00794	0.00821	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00777	0.00804	CcSEcCtD
Cisatracurium Besylate—Myopathy—Betamethasone—multiple sclerosis	0.00765	0.00792	CcSEcCtD
Cisatracurium Besylate—Myopathy—Dexamethasone—multiple sclerosis	0.00765	0.00792	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Cladribine—multiple sclerosis	0.00763	0.0079	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Fingolimod—multiple sclerosis	0.00736	0.00761	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Methotrexate—multiple sclerosis	0.00733	0.00758	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Fingolimod—multiple sclerosis	0.00729	0.00754	CcSEcCtD
Cisatracurium Besylate—Hypotension—Fingolimod—multiple sclerosis	0.00701	0.00725	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Fingolimod—multiple sclerosis	0.00669	0.00692	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisone—multiple sclerosis	0.00666	0.00689	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Methotrexate—multiple sclerosis	0.00615	0.00636	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Cladribine—multiple sclerosis	0.00588	0.00609	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00588	0.00608	CcSEcCtD
Cisatracurium Besylate—Wheezing—Triamcinolone—multiple sclerosis	0.00574	0.00594	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Cladribine—multiple sclerosis	0.00543	0.00562	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Cladribine—multiple sclerosis	0.00541	0.0056	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Cladribine—multiple sclerosis	0.0054	0.00558	CcSEcCtD
Cisatracurium Besylate—Pruritus—Fingolimod—multiple sclerosis	0.00531	0.00549	CcSEcCtD
Cisatracurium Besylate—Erythema—Cladribine—multiple sclerosis	0.00521	0.00539	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisolone—multiple sclerosis	0.00508	0.00525	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00482	0.00499	CcSEcCtD
Cisatracurium Besylate—Injury—Triamcinolone—multiple sclerosis	0.00467	0.00483	CcSEcCtD
Cisatracurium Besylate—Injury—Methylprednisolone—multiple sclerosis	0.00466	0.00482	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisolone—multiple sclerosis	0.00444	0.00459	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00443	0.00459	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00442	0.00458	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00441	0.00456	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Azathioprine—multiple sclerosis	0.0044	0.00455	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00439	0.00454	CcSEcCtD
Cisatracurium Besylate—Injury—Dexamethasone—multiple sclerosis	0.00424	0.00438	CcSEcCtD
Cisatracurium Besylate—Injury—Betamethasone—multiple sclerosis	0.00424	0.00438	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Cladribine—multiple sclerosis	0.00417	0.00432	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Cladribine—multiple sclerosis	0.00415	0.0043	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Cladribine—multiple sclerosis	0.00413	0.00428	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisolone—multiple sclerosis	0.00412	0.00426	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00408	0.00422	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00407	0.00421	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00402	0.00416	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00402	0.00416	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Mitoxantrone—multiple sclerosis	0.00401	0.00415	CcSEcCtD
Cisatracurium Besylate—Hypotension—Cladribine—multiple sclerosis	0.00397	0.00411	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Cladribine—multiple sclerosis	0.00379	0.00392	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Triamcinolone—multiple sclerosis	0.00378	0.00392	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Methylprednisolone—multiple sclerosis	0.00378	0.00391	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Dexamethasone—multiple sclerosis	0.0037	0.00383	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Betamethasone—multiple sclerosis	0.0037	0.00383	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisone—multiple sclerosis	0.00369	0.00382	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Methylprednisolone—multiple sclerosis	0.00364	0.00377	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00358	0.00371	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Dexamethasone—multiple sclerosis	0.00343	0.00355	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Betamethasone—multiple sclerosis	0.00343	0.00355	CcSEcCtD
Cisatracurium Besylate—Erythema—Mitoxantrone—multiple sclerosis	0.00343	0.00354	CcSEcCtD
Cisatracurium Besylate—Urticaria—Cladribine—multiple sclerosis	0.00338	0.0035	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Azathioprine—multiple sclerosis	0.00336	0.00348	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisolone—multiple sclerosis	0.00329	0.0034	CcSEcCtD
Cisatracurium Besylate—Hypotension—Azathioprine—multiple sclerosis	0.00323	0.00334	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisone—multiple sclerosis	0.00322	0.00334	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Cladribine—multiple sclerosis	0.00313	0.00324	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Triamcinolone—multiple sclerosis	0.00302	0.00313	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Methylprednisolone—multiple sclerosis	0.00302	0.00312	CcSEcCtD
Cisatracurium Besylate—Pruritus—Cladribine—multiple sclerosis	0.00301	0.00311	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisone—multiple sclerosis	0.00299	0.00309	CcSEcCtD
Cisatracurium Besylate—Convulsion—Mitoxantrone—multiple sclerosis	0.00297	0.00307	CcSEcCtD
Cisatracurium Besylate—Hypertension—Mitoxantrone—multiple sclerosis	0.00296	0.00306	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00293	0.00303	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00291	0.00301	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisolone—multiple sclerosis	0.00281	0.00291	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.0028	0.00289	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Betamethasone—multiple sclerosis	0.00274	0.00284	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Dexamethasone—multiple sclerosis	0.00274	0.00284	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Mitoxantrone—multiple sclerosis	0.00273	0.00282	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Mitoxantrone—multiple sclerosis	0.00272	0.00281	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methylprednisolone—multiple sclerosis	0.00269	0.00278	CcSEcCtD
Cisatracurium Besylate—Rash—Cladribine—multiple sclerosis	0.00268	0.00278	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Cladribine—multiple sclerosis	0.00268	0.00277	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00268	0.00277	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00267	0.00276	CcSEcCtD
Cisatracurium Besylate—Hypotension—Mitoxantrone—multiple sclerosis	0.00261	0.0027	CcSEcCtD
Cisatracurium Besylate—Erythema—Triamcinolone—multiple sclerosis	0.00258	0.00267	CcSEcCtD
Cisatracurium Besylate—Erythema—Methylprednisolone—multiple sclerosis	0.00258	0.00267	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisolone—multiple sclerosis	0.00257	0.00266	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Azathioprine—multiple sclerosis	0.00255	0.00264	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00249	0.00258	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Betamethasone—multiple sclerosis	0.00244	0.00253	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Dexamethasone—multiple sclerosis	0.00244	0.00253	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisolone—multiple sclerosis	0.00243	0.00252	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisolone—multiple sclerosis	0.00243	0.00251	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisone—multiple sclerosis	0.00239	0.00247	CcSEcCtD
Cisatracurium Besylate—Angioedema—Triamcinolone—multiple sclerosis	0.00236	0.00244	CcSEcCtD
Cisatracurium Besylate—Angioedema—Methylprednisolone—multiple sclerosis	0.00236	0.00244	CcSEcCtD
Cisatracurium Besylate—Erythema—Dexamethasone—multiple sclerosis	0.00234	0.00243	CcSEcCtD
Cisatracurium Besylate—Erythema—Betamethasone—multiple sclerosis	0.00234	0.00243	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Prednisone—multiple sclerosis	0.00231	0.00239	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00229	0.00237	CcSEcCtD
Cisatracurium Besylate—Convulsion—Triamcinolone—multiple sclerosis	0.00224	0.00232	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisolone—multiple sclerosis	0.00224	0.00232	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methylprednisolone—multiple sclerosis	0.00223	0.00231	CcSEcCtD
Cisatracurium Besylate—Hypertension—Triamcinolone—multiple sclerosis	0.00223	0.00231	CcSEcCtD
Cisatracurium Besylate—Hypertension—Methylprednisolone—multiple sclerosis	0.00223	0.0023	CcSEcCtD
Cisatracurium Besylate—Urticaria—Mitoxantrone—multiple sclerosis	0.00222	0.0023	CcSEcCtD
Cisatracurium Besylate—Rash—Azathioprine—multiple sclerosis	0.00218	0.00226	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00218	0.00226	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Azathioprine—multiple sclerosis	0.00218	0.00225	CcSEcCtD
Cisatracurium Besylate—Flushing—Prednisone—multiple sclerosis	0.00218	0.00225	CcSEcCtD
Cisatracurium Besylate—Angioedema—Dexamethasone—multiple sclerosis	0.00214	0.00222	CcSEcCtD
Cisatracurium Besylate—Angioedema—Betamethasone—multiple sclerosis	0.00214	0.00222	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Prednisone—multiple sclerosis	0.00213	0.0022	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Prednisone—multiple sclerosis	0.00212	0.00219	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00211	0.00218	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.0021	0.00218	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00206	0.00214	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00206	0.00213	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Triamcinolone—multiple sclerosis	0.00206	0.00213	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Methylprednisolone—multiple sclerosis	0.00205	0.00213	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methylprednisolone—multiple sclerosis	0.00204	0.00212	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisone—multiple sclerosis	0.00204	0.00211	CcSEcCtD
Cisatracurium Besylate—Convulsion—Dexamethasone—multiple sclerosis	0.00203	0.0021	CcSEcCtD
Cisatracurium Besylate—Convulsion—Betamethasone—multiple sclerosis	0.00203	0.0021	CcSEcCtD
Cisatracurium Besylate—Hypertension—Betamethasone—multiple sclerosis	0.00202	0.00209	CcSEcCtD
Cisatracurium Besylate—Hypertension—Dexamethasone—multiple sclerosis	0.00202	0.00209	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methylprednisolone—multiple sclerosis	0.00197	0.00203	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00191	0.00198	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00191	0.00198	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Triamcinolone—multiple sclerosis	0.00188	0.00195	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Betamethasone—multiple sclerosis	0.00188	0.00194	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00188	0.00194	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Betamethasone—multiple sclerosis	0.00187	0.00193	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Dexamethasone—multiple sclerosis	0.00187	0.00193	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisone—multiple sclerosis	0.00187	0.00193	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisolone—multiple sclerosis	0.00182	0.00189	CcSEcCtD
Cisatracurium Besylate—Hypotension—Betamethasone—multiple sclerosis	0.00179	0.00185	CcSEcCtD
Cisatracurium Besylate—Hypotension—Dexamethasone—multiple sclerosis	0.00179	0.00185	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—multiple sclerosis	0.00178	0.00184	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—multiple sclerosis	0.00177	0.00183	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisone—multiple sclerosis	0.00177	0.00183	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00177	0.00183	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisone—multiple sclerosis	0.00176	0.00182	CcSEcCtD
Cisatracurium Besylate—Rash—Mitoxantrone—multiple sclerosis	0.00176	0.00182	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Mitoxantrone—multiple sclerosis	0.00176	0.00182	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00173	0.00179	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—multiple sclerosis	0.00171	0.00177	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisolone—multiple sclerosis	0.00169	0.00175	CcSEcCtD
Cisatracurium Besylate—Urticaria—Triamcinolone—multiple sclerosis	0.00168	0.00173	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methylprednisolone—multiple sclerosis	0.00167	0.00173	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisone—multiple sclerosis	0.00167	0.00172	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Prednisone—multiple sclerosis	0.00163	0.00169	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisone—multiple sclerosis	0.00163	0.00168	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Prednisone—multiple sclerosis	0.00162	0.00168	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00155	0.00161	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Cisatracurium Besylate—Urticaria—Dexamethasone—multiple sclerosis	0.00152	0.00157	CcSEcCtD
Cisatracurium Besylate—Urticaria—Betamethasone—multiple sclerosis	0.00152	0.00157	CcSEcCtD
Cisatracurium Besylate—Pruritus—Triamcinolone—multiple sclerosis	0.00149	0.00154	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methylprednisolone—multiple sclerosis	0.00149	0.00154	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—multiple sclerosis	0.00148	0.00153	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisolone—multiple sclerosis	0.00145	0.0015	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisolone—multiple sclerosis	0.00144	0.0015	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00144	0.00149	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00139	0.00144	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—multiple sclerosis	0.00137	0.00141	CcSEcCtD
Cisatracurium Besylate—Pruritus—Betamethasone—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Cisatracurium Besylate—Pruritus—Dexamethasone—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Cisatracurium Besylate—Rash—Triamcinolone—multiple sclerosis	0.00133	0.00138	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Triamcinolone—multiple sclerosis	0.00133	0.00137	CcSEcCtD
Cisatracurium Besylate—Rash—Methylprednisolone—multiple sclerosis	0.00133	0.00137	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methylprednisolone—multiple sclerosis	0.00133	0.00137	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisone—multiple sclerosis	0.00132	0.00137	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—multiple sclerosis	0.0013	0.00135	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—multiple sclerosis	0.00124	0.00129	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Cisatracurium Besylate—Rash—Dexamethasone—multiple sclerosis	0.00121	0.00125	CcSEcCtD
Cisatracurium Besylate—Rash—Betamethasone—multiple sclerosis	0.00121	0.00125	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Betamethasone—multiple sclerosis	0.00121	0.00125	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Dexamethasone—multiple sclerosis	0.00121	0.00125	CcSEcCtD
Cisatracurium Besylate—Pruritus—Prednisone—multiple sclerosis	0.00118	0.00122	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—multiple sclerosis	0.00111	0.00115	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisone—multiple sclerosis	0.00105	0.00109	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisone—multiple sclerosis	0.00105	0.00109	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—multiple sclerosis	0.000985	0.00102	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—multiple sclerosis	0.000878	0.000909	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—multiple sclerosis	0.000877	0.000908	CcSEcCtD
